United Therapeutics Corporation (NASDAQ:UTHR) Q3 2023 Earnings Call Transcript

Page 4 of 4

Martine Rothblatt: Thank you so much, Dr. Peterson. Ash, thank you so much for the question. In conclusion, as mentioned earlier, we’re really happy to be in such a great position here at United Therapeutics. We have a solid commercial business posting record results with continued strong growth ahead. We have a pipeline of novel therapies that could again double our revenue by the end of the decade. And we have a long-term plan to address one of the largest critical unmet medical needs. All of the above, while helping our patients, employees, and shareholders succeed. Operator, you may now terminate the call.

Operator: Thank you for participating in today’s United Therapeutics Corporation earnings webcast. A re-broadcast of this webcast will be available for replay for one week by visiting the events and presentation section of the United Therapeutics Investor Relations website at ir.unither.com. You may now disconnect your lines and have a wonderful day.

Follow United Therapeutics Corp (NASDAQ:UTHR)

Page 4 of 4